
Teva Recalls One Lot of Anagrelide Capsules, USP 0.5 mg Because It Failed Dissolution Test
Teva Pharmaceuticals USA has issued a voluntary nationwide recall of one lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090). The consumer-level recall is










